Nivolumab plus lowdose ipilimumab promising for treatmentnaïve MSIhigh mCRC HeinzJosef Lenz

>> DOWNLOAD LINK 🎞️ #1 <<

>> DOWNLOAD LINK 🎞️ #2 <<

>> DOWNLOAD LINK 🎵 MP3 <<

############################# Video Source: www.youtube.com/watch?v=sOM7mqH_z3o

Heinz-Josef Lenz outlines the results of CheckMate-142 study investigating combination immunotherapy in the first-line treatment of patients with MSI-high metastatic colorectal cancer, and discusses the unmet needs of those with MSI-low tumors. • View more on Medicine Matters oncology: https://bit.ly/Lenz-CheckMate-142-study • More from ESMO 2018: https://bit.ly/ESMO-2018-conference-hub • Originally published on Medicine Matters oncology on October 30, 2018

#############################